Researchers have been exploring the potential of laser light therapy in a number of disease states for quite a while.
Poulsbo, Washington startup LumiThera is developing an LED light-based instrument, for use in an ophthalmologist’s office, to treat the dry form of acute macular degeneration. The company uses low-level light therapy, or LLLT, in which patients are exposed to low-level laser lights to stimulate cellular function.
LumiThera says patients with dry acute macular degeneration have improved eyesight in its pilot clinical study with low-level laser therapy, with up to one year follow-up. It is raising $3 million to expand this technology, according to a regulatory filing. Thus far, it has raised $325,000